Researcher.Life Logo

Advances in Hematology : Impact Factor & More

eISSN: 1687-9112pISSN: 1687-9104
JournalOpen Access

Key Metrics

CiteScore
2.8
H-Index
36
SJR
Q3Hematology
SNIP
0.95
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Advances in Hematology

Advances in Hematology Journal Specifications

Overview
Publisher Hindawi
Language English
Article Processing ChargesUSD 800
Publication Time15
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
Website URLVisit website
Publication Details
Other chargesVisit website
PlagiarismVisit website
Publication Time 15
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY
OA statementVisit website
View less

Planning to publish in Advances in Hematology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Advances in Hematology

Optimizing Testing Time for Methaemoglobin Reduction Test in G6PD Screening: A Comparative Study of Monica Cheesbrough’s Protocol and a Modified Approach at a Hospital in a Resource‐Restraint Country, Ghana
  • 20 Nov 2025
  • Advances in Hematology
Treatment Patterns and Outcomes of Patients With Myelodysplastic Syndrome (MDS) by IPSS‐R Scores at Academic Cancer Centers
  • 19 Nov 2025
  • Advances in Hematology
A Novel Strategy for Assessing Bone Marrow Plasma Cell Percentage: Development and Internal Validation of a Surrogate Calculation Approach
  • 14 Nov 2025
  • Advances in Hematology
Exploring Adverse Blood Donation Reactions Among Whole Blood Donors at a Tertiary Hospital Setting: A One‐Center Observational Mixed‐Methods Study
  • 29 Oct 2025
  • Advances in Hematology
Soluble B‐cell Maturation Antigen in Multiple Myeloma and Correlation With Response to Therapy
  • 15 Oct 2025
  • Advances in Hematology
Newly Diagnosed High-Risk Multiple Myeloma: Outcomes and Management
  • 26 Sep 2025
  • Advances in Hematology
Optimizing Testing Time for Methaemoglobin Reduction Test in G6PD Screening: A Comparative Study of Monica Cheesbrough’s Protocol and a Modified Approach at a Hospital in a Resource‐Restraint Country, Ghana
  • 20 Nov 2025
  • Advances in Hematology
Treatment Patterns and Outcomes of Patients With Myelodysplastic Syndrome (MDS) by IPSS‐R Scores at Academic Cancer Centers
  • 19 Nov 2025
  • Advances in Hematology
A Novel Strategy for Assessing Bone Marrow Plasma Cell Percentage: Development and Internal Validation of a Surrogate Calculation Approach
  • 14 Nov 2025
  • Advances in Hematology
Exploring Adverse Blood Donation Reactions Among Whole Blood Donors at a Tertiary Hospital Setting: A One‐Center Observational Mixed‐Methods Study
  • 29 Oct 2025
  • Advances in Hematology
Soluble B‐cell Maturation Antigen in Multiple Myeloma and Correlation With Response to Therapy
  • 15 Oct 2025
  • Advances in Hematology
Newly Diagnosed High-Risk Multiple Myeloma: Outcomes and Management
  • 26 Sep 2025
  • Advances in Hematology

FAQs on Advances in Hematology